2
Clinical Trials associated with BionetideA Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Bionetide for the Treatment of Girls and Women With Rett Syndrome
Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome
Key Secondary Objective
• To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and women with Rett syndrome
A Randomized, Double-Blind, Placebo-Controlled, Phase 2/ Phase 3 Study of NA-921 (Bionetide) for the Treatment of Girls and Women with Rett Syndrome
To study the efficacy & safety of oral Bionetide versus placebo in girls and women with Rett syndrome
100 Clinical Results associated with Bionetide
100 Translational Medicine associated with Bionetide
100 Patents (Medical) associated with Bionetide
100 Deals associated with Bionetide